Suppr超能文献

埃及丙型肝炎病毒相关肝硬化患者自发性细菌性腹膜炎患者血清和腹水白细胞介素-17水平

Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis.

作者信息

Keryakos Hesham Kamal Habeeb, Mohammed Ahmed Ali, Higazi Aliaa Monir, Mahmoud Esraa Abdel Magid, Saad Zienab Mostafa

机构信息

Department of Internal Medicine, Minia Faculty of Medicine, Minia University Hospital, El-Minia, Egypt.

Department of Internal Medicine, Minia Faculty of Medicine, Minia University Hospital, El-Minia, Egypt.

出版信息

Curr Res Transl Med. 2020 Nov;68(4):237-243. doi: 10.1016/j.retram.2020.03.001. Epub 2020 Jul 1.

Abstract

BACKGROUND

Spontaneous bacterial peritonitis (SBP) is a potentially lethal complication of ascites. The inflammatory response is very intense in case of SBP despite low concentration of bacteria in the ascitic fluid with IL-17A overproduced by intestinal Paneth cells and may have role in host immune defense and inflammatory response.

AIMS

To study the diagnostic performance of serum and ascitic fluid IL-17A as a marker of SBP and its correlation with renal function.

METHODS

120 cirrhotic patients including 80 patients with HCV-induced cirrhotic ascites but not with SBP and 40 patients with HCV-induced cirrhotic ascites with SBP were recruited. Serum and ascitic fluid IL17A were measured before and after treatment.

RESULTS

The mean serum and ascitic fluid levels of IL-17 in cirrhotic patients with SBP were significantly higher than in patients with cirrhosis without SBP (p < 0.001). Also, we found significant decline in both serum and ascitic fluid IL17 levels with successful treatment of SBP (p < 0.001). The sensitivity and specificity of serum IL17 was 100 % when using 92 pg/mL as cutoff. Meanwhile, sensitivity and specificity of ascitic fluid IL-17were 100 % when using 132 pg/mL as cutoff.

CONCLUSIONS

IL-17 could be used as a possible diagnostic biomarker for SBP especially in culture negative and non-neutrocytic SBP and in monitoring therapeutic response. Also, it was shown to be related to hepatic and renal functions deterioration.

摘要

背景

自发性细菌性腹膜炎(SBP)是腹水的一种潜在致命并发症。尽管腹水细菌浓度较低,但SBP时炎症反应非常强烈,肠道潘氏细胞过度产生白细胞介素-17A(IL-17A),其可能在宿主免疫防御和炎症反应中起作用。

目的

研究血清和腹水IL-17A作为SBP标志物的诊断性能及其与肾功能的相关性。

方法

招募120例肝硬化患者,其中80例丙型肝炎病毒(HCV)诱导的肝硬化腹水患者但无SBP,40例HCV诱导的肝硬化腹水合并SBP患者。在治疗前后检测血清和腹水IL-17A。

结果

SBP肝硬化患者的血清和腹水IL-17平均水平显著高于无SBP的肝硬化患者(p < 0.001)。此外,我们发现SBP成功治疗后血清和腹水IL-17水平均显著下降(p < 0.001)。以92 pg/mL为临界值时,血清IL-17的敏感性和特异性为100%。同时,以132 pg/mL为临界值时,腹水IL-17的敏感性和特异性为100%。

结论

IL-17可作为SBP的一种可能的诊断生物标志物,尤其是在培养阴性和非中性粒细胞性SBP中,以及在监测治疗反应方面。此外,它还与肝肾功能恶化有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验